Organic compounds

Details for Australian Patent Application No. 2007318220 (hide)

Owner Novartis AG

Inventors Zawel, Leigh; Porter, Dale Alan; Gaither, Larry Alexander; Straub, Christopher Sean; Yao, Yao; Iourgenko, Vadim; Labow, Mark Aron

Agent Davies Collison Cave

Pub. Number AU-A-2007318220

PCT Pub. Number WO2008/057172

Priority 60/862,161 19.10.06 US; 60/862,155 19.10.06 US

Filing date 17 October 2007

Wipo publication date 15 May 2008

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/057172 Priority application(s): WO2008/057172

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318244-Multi-substituted pyridyl sulfoximines and their use as insecticides

2007318219-4-1 BB ligand in inflammatory diseases